36E79718R0016-00001000.docx

5. PROJECT NUMBER (if applicable)

CODE

7. ADMINISTERED BY

2. AMENDMENT/MODIFICATION NUMBER

CODE

6. ISSUED BY

8. NAME AND ADDRESS OF CONTRACTOR

4. REQUISITION/PURCHASE REQ. NUMBER

3. EFFECTIVE DATE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED

PAGE

OF PAGES

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED

BPA NO.

1. CONTRACT ID CODE

FACILITY CODE

CODE

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

E. IMPORTANT:

is extended,

(a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY is not extended.

12. ACCOUNTING AND APPROPRIATION DATA

(REV. 11/2016)

is required to sign this document and return ___________ copies to the issuing office.

is not, A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

15C. DATE SIGNED

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER

BY

Contractor

16C. DATE SIGNED

14. DESCRIPTION OF AMENDMENT/MODIFICATION

16B. UNITED STATES OF AMERICA

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER

16A. NAME AND TITLE OF CONTRACTING OFFICER

15B. CONTRACTOR/OFFEROR

STANDARD FORM 30

PREVIOUS EDITION NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.243 (Type or print) (Type or print) (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

(Number, street, county, State and ZIP Code) (If other than Item 6) (Specify type of modification and authority) (such as changes in paying office, appropriation date, etc.)

(If required)

(SEE ITEM 11)

(SEE ITEM 13)

(X)

CHECK

ONE

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

(Signature of person authorized to sign) (Signature of Contracting Officer) 00001 04-10-2018 Department of Veterans Affairs OPAL/National Acquisition Center Building 37 1st Avenue, One Block North of Cermak Hines

IL

60141 Department of Veterans Affairs OPAL / National Acquisition Center Building 37 1st Avenue, One Block North of Cermak Hines

IL

60141 To all Offerors/Bidders

36E79718R0016 04-10-2018

X X X One This amendment is issued to correct the package size listed for Atorvastatin 20MG Tablets 4a or 4b on page 3 of the solicitation. Please see the the corrected package sizes listed for Atorvastatin 20MG Tablets on the following pages:

OFFERS ARE STILL DUE 4-18-2018, 2:30PM CENTRAL TIME

ALL OTHER CONTRACT TERMS AND CONDITIONS OF THIS SOLICITATION REMAIN UNCHANGED.

19.

Item No.

20.

Schedule of Supplies/Services

21. Quantity 22.

Unit 23.

Unit Price 24.

Amount

To be considered for award, offerors must submit a price for line items 1, 2a or 2b, 3, 4a or 4b, 5, 6a or 6b, 7 and 8a or 8b for the base year and all four option years. One award will be made in the aggregate for line items 1, 2a or 2b, 3, 4a or 4b, 5, 6a or 6b, 7 and 8a or 8b for the base years and all four options. Offered prices shall not exceed two decimal places. The Government reserves the right not to award a contract on this solicitation should offered prices match or exceed current Federal Supply Schedule prices.

Line items 2a or 2b, 4a or 4b, 6a or 6b, and 8a or 8b are for bulk requirement and will be accepted in their bottles of 500s OR 1000s. Offerors must submit prices for either 500s OR 1000s. If both sub-line items are offered, only the lower priced product (i.e. based on a per tablet price) will be included in the calculation of the lowest total aggregate price for evaluation of award.

All unit-of-use packaging identified in the Schedule of Supplies (i.e., 30s, 90s) must contain a child proof closure (safety cap) and a bottle with a minimum required size of 100cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75” circumference. The bottle must fit a label with a dimension of 5.25” x 2”. The 0.5” additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Glass bottles are not acceptable.

Line Item 1

Atorvastatin CA Tab, 10MG, 90s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 315,618 BT $_________ $__________ Option Year One 315,618 BT $_________ $__________ Option Year Two 315,618 BT $_________ $__________ Option Year Three 315,618 BT $_________ $__________ Option Year Four 315,618 BT $_________ $__________

Line Item 2a

Atorvastatin CA Tab, 10MG, 500s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 82,232 BT $_________ $__________ Option Year One 82,232 BT $_________ $__________ Option Year Two 82,232 BT $_________ $__________ Option Year Three 82,232 BT $_________ $__________ Option Year Four 82,232 BT $_________ $__________

OR

Line Item 2b

Atorvastatin CA Tab, 10MG, 1000s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 41,116 BT $_________ $__________ Option Year One 41,116 BT $_________ $__________ Option Year Two 41,116 BT $_________ $__________ Option Year Three 41,116 BT $_________ $__________ Option Year Four 41,116 BT $_________ $__________

Line Item 3

Atorvastatin CA Tab, 20MG, 90s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 433,765 BT $_________ $__________ Option Year One 433,765 BT $_________ $__________ Option Year Two 433,765 BT $_________ $__________ Option Year Three 433,765 BT $_________ $__________ Option Year Four 433,765 BT $_________ $__________

Line Item 4a

Atorvastatin CA Tab, 20MG, 500s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 156,406 BT $_________ $__________ Option Year One 156,406 BT $_________ $__________ Option Year Two 156,406 BT $_________ $__________ Option Year Three 156,406 BT $_________ $__________ Option Year Four 156,406 BT $_________ $__________

OR

Line Item 4b

Atorvastatin CA Tab, 20MG, 1000s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 78,203 BT $_________ $__________ Option Year One 78,203 BT $_________ $__________ Option Year Two 78,203 BT $_________ $__________ Option Year Three 78,203 BT $_________ $__________ Option Year Four 78,203 BT $_________ $__________

Line Item 5

Atorvastatin CA Tab, 40MG, 90s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 777,013 BT $_________ $__________ Option Year One 777,013 BT $_________ $__________ Option Year Two 777,013 BT $_________ $__________ Option Year Three 777,013 BT $_________ $__________ Option Year Four 777,013 BT $_________ $__________

Line Item 6a

Atorvastatin CA Tab, 40MG, 500s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 153,986 BT $_________ $__________ Option Year One 153,986 BT $_________ $__________ Option Year Two 153,986 BT $_________ $__________ Option Year Three 153,986 BT $_________ $__________ Option Year Four 153,986 BT $_________ $__________

OR

Line Item 6b

Atorvastatin CA Tab, 40MG, 1000s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 76,993 BT $_________ $__________ Option Year One 76,993 BT $_________ $__________ Option Year Two 76,993 BT $_________ $__________ Option Year Three 76,993 BT $_________ $__________ Option Year Four 76,993 BT $_________ $__________

Line Item 7

Atorvastatin CA Tab, 80MG, 90s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 751,982 BT $_________ $__________ Option Year One 751,982 BT $_________ $__________ Option Year Two 751,982 BT $_________ $__________ Option Year Three 751,982 BT $_________ $__________ Option Year Four 751,982 BT $_________ $__________

Line Item 8a

Atorvastatin CA Tab, 80MG, 500s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 144,664 BT $_________ $__________ Option Year One 144,664 BT $_________ $__________ Option Year Two 144,664 BT $_________ $__________ Option Year Three 144,664 BT $_________ $__________ Option Year Four 144,664 BT $_________ $__________

OR

Line Item 8b

Atorvastatin CA Tab, 80MG, 1000s

NDC # __________________

ANDA#_________________

Est.Ann Qty Base Year 72,332 BT $_________ $__________ Option Year One 72,332 BT $_________ $__________ Option Year Two 72,332 BT $_________ $__________ Option Year Three 72,332 BT $_________ $__________ Option Year Four 72,332 BT $_________ $__________